AUTHOR=Bao Peng , Sun Yuzhen , Qiu Peng , Li Xiaohui 

TITLE=Development and validation of a nomogram to predict the risk of vancomycin-related acute kidney injury in critical care patients

JOURNAL=Frontiers in Pharmacology

VOLUME=Volume 15 - 2024

YEAR=2024

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1389140

DOI=10.3389/fphar.2024.1389140

ISSN=1663-9812

ABSTRACT=Background: Vancomycin-associated acute kidney injury (AKI) leads to underestimated morbidity in the intensive care unit (ICU). It is significantly important to predict its occurrence in advance. However, risk factors and nomograms to predict this AKI is limited.: This was a retrospective analysis of two databases. 1959 patients diagnosed with AKI treated with vancomycin were enrolled from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. According to the 7:3 ratio, the training set (n = 1372) and the internal validation set (n = 587) are randomly allocated. The external validation set included 211 patients from the eICU Collaborative Research Database (eICU). Next, to screen potential variables, the least absolute shrinkage and selection operator (LASSO) regression was utilized. Subsequently, the nomogram was developed by the variables of the selected results in the multivariable logistic regression. Finally, discrimination, calibration and clinical utility were evaluated to validate the nomogram. Results: The constructed nomogram showed fine discrimination in the training set (area under the receiver operator characteristic curve (AUC) = 0.791; 95% confidence interval (CI) 0.758-0.823) the internal validation set (AUC=0.793; 95% CI 0.742-0.844) and external validation set (AUC=0.755; 95% CI 0.663-0.847). Moreover, it also demonstrated well calibration and clinical utility. The significant improvement (P < 0.001) of net reclassification improvement (NRI) and integrated differentiation improvement (IDI) confirmed that the predictive model outperformed others. Conclusion: This established nomogram indicated promising performance in determining individual AKI risk of vancomycin-treated critical care patients, which will be beneficial to make clinical decisions.